Eric M. Verdin

Eric M. Verdin is a Belgian geroscientist, researcher, and professor who has served as president and chief executive officer of the Buck Institute for Research on Aging since 2016. Verdin’s research focuses on metabolism, diet, and the different proteins and molecules that affect the aging process and its associated diseases. He has published more than 210 papers and has more than 15 patents.

Life and career Eric M. Verdin was born in Belgium. He has a BS in Medical Sciences and doctorate of medicine from the University of Liege. He previously held faculty positions at the National Institutes of Health and at Picower Institute for Medical Research. He is an inventor on at least 15 published patents.

Research focus areas Verdin’s research has seen him focus on:

Epigenetic regulation: His research career began with a focus on epigenetic regulation, and for many years he worked primarily on the biology of HIV, with a particular emphasis on transcriptional regulation and the role of chromatin Sirtuins: a family of proteins that influence the aging process by inhibiting histone deacetylases (HDACs) through epigenetics Ketone bodies: created from fatty acids by the liver and used as an energy source during periods when carbs are not available NAD+: the oxidized form of NAD At Gladstone, Verdin researched the role of metabolism and diet in aging and on chronic diseases of aging, including Alzheimer’s. and has published more than 210 scientific papers including: